Historically, the evaluation and management of atherosclerotic renal artery disease focused on the presence and treatment of associated hypertension. In recent years, however, the relationship between renal artery disease and excretory renal insufficiency (ie, ischemic nephropathy) has received increased attention as an important cause of progressive renal failure. 1, 2 Despite this recognized relationship, enthusiasm for treatment of ischemic nephropathy varies widely. In some instances, authors caution against renal artery intervention for ischemic nephropathy, citing uncertain renal function response in a patient population characterized by diffuse extrarenal atherosclerosis and limited longterm survival. [3] [4] [5] [6] Conversely, others have recommended intervention for asymptomatic renal artery lesions (ie, without hypertension or renal insufficiency), fearing inevitable and irretrievable loss of renal function. [7] [8] [9] [10] In addition to these controversies, opinions regarding the preferred method of renal artery intervention are equally diverse. Proponents of percutaneous transluminal balloon angioplasty (PTA) and proponents of surgical repair cite selected clinical series to support their respective views. Unfortunately, data pertaining to the primary goals of both PTA and surgery-increased renal function and improved dialysis-free survival-are incomplete for ischemic nephropathy. 1, 5, 11, 12 Consequently, management choices often emphasize perceived differences in morbidity and stress immediate technical results rather than long-term outcome.
This retrospective review of a single center's cumulative experience with atherosclerotic renal artery disease describes the operative management of consecutive hypertensive patients with ischemic nephropathy. In addition to the immediate blood pressure and renal function response after operation, specific points of interest included (1) preoperative predictors of dialysis-free survival and (2) the effect of blood pressure and renal function response on eventual dialysis dependence and dialysis-free survival.
PATIENTS AND METHODS
Patient population. From January 1987 through December 1998, a total of 590 patients underwent surgical repair of renal artery disease at the authors' center. After removal from high-dose diuretics, converting enzyme inhibitors, and angiotensin receptor antagonists, each of 232 patients with atherosclerotic renovascular disease had a preoperative serum creatinine (SCr) level of 1.8 mg/dL or more; included were 38 patients dependent on dialysis. These 232 patients were considered to have ischemic nephropathy, and they con- Graphic depiction of interaction between graded renal function response to operation, preoperative EGFR, and effect on follow-up death or dialysis dependence among patients with ischemic nephropathy. Curves show estimated hazard ratio for patients with "no change" vs "improved" function (solid curve) and associated upper and lower 95% confidence limits (broken curve) for values of preoperative EGFR, ranging from 5 to 35 mL/min/m 2 . Horizontal line at 1.0 denotes value of no association. 95% CI for hazard ratio includes 1.0 for preoperative EGFR more than 23 mL/min/m 2 . Severe hypertension was present in each patient (mean blood pressure, 204 ± 34/106 ± 21 mm Hg; mean number of medications, 2.8 ± 1.1) and ranged in duration from 9 to 57 years (mean, 11 years). In addition to severe hypertension in combination with excretory renal insufficiency, extrarenal atherosclerosis was evidenced by cardiac disease (68%), cerebral vascular disease (32%), and aortoiliac disease (60%). Only 30 patients (13%) were free of clinical extrarenal atherosclerosis (Table I ). In addition, type 2 diabetes had been diagnosed in 35 patients (15%) with 3 to 22 years (mean, 12.2 years) before operation.
Patient evaluation. After physical examination, electrocardiography, and the taking of a complete medical history, 197 patients underwent further cardiac evaluation. These evaluations included resting and/or stress echocardiography (191 patients), stress electrocardiography (12 patients), and cardiac catheterization (28 patients) and resulted in 15 coronary interventions (11 percutaneous transluminal coronary angioplasties and 4 coronary artery bypass grafts) preliminary to renal artery repair.
Cut-film angiography demonstrated significant unilateral renal artery disease (≥ 80% orificial stenosis or occlusion) in 83 patients and bilateral disease in 149 patients, including 17 patients each having significant disease to a solitary kidney. In all, 116 complete renal artery occlusions were observed in 109 patients. Concomitant severe aortic occlusive disease, including 21 aortic occlusions, was found in 108 patients, and a significant abdominal aortic aneurysm was demonstrated in 57 patients.
Fifty-one patients with hypertension under satisfactory medical control who demonstrated unilateral renovascular disease were studied with renal vein renin assays or split renal function tests. Lateralization was observed in 29 patients. Isotopic renography was performed in 57 patients before surgical repair. Fortythree kidneys with significant renal artery disease supplied less than 10% to 20% of total renal function.
Operative management. Renal artery reconstruction was performed in every instance of significant renal artery disease when a normal distal renal artery could be demonstrated at surgery. Primary nephrectomy was reserved for an unreconstructable renal artery to a kidney providing less than 10% to 20% of total renal function by preoperative renography. Eighty-three patients underwent unilateral renal artery repair; 122 patients had bilateral repair, including 17 patients each having a solitary kidney; and 27 patients had unilateral repair with contralateral nephrectomy. Direct aortorenal reconstruction to 328 kidneys included aortorenal bypass (210 instances), thromboendarterectomy (103 instances), and reimplantation (15 instances For female subjects, the EGFR was multiplied by 0.85 to correct for sex-related differences in muscle mass and average rate of creatinine synthesis.
Descriptive statistics for factors of interest were computed for patients with ischemic nephropathy (SCr levels of ≥ 1.8 mg/dL). Changes in EGFR versus site of disease were assessed through use of unpaired t tests to test between-group differences in preoperative levels, paired t tests to assess for preoperative to postoperative within-group changes, and analysis of covariance (controlling for preoperative EGFR) to test for between-group differences in postoperative levels. Three long-term follow-up outcomes were examined: (1) survival time, (2) dialysis-free time, and (3) dialysis-free survival (ie, time to death or dialysis, whichever occurred first). These outcomes were depicted graphically through use of KaplanMeier product-limit estimates. 14 In the group with SCr levels of 1.8 mg/dL or more, examination of the effect of renal function response to operation on each outcome was assessed through use of multivariable Cox proportional hazards models. 15 Separate "best" models were selected for each outcome through use of a backward stepwise elimination technique whereby all factors of interest were included in the first step and factors not significant at the .10 α-level were eliminated one by one until all factors remaining in the model were significant at the .10 level. 15 
RESULTS

Postoperative morbidity and mortality
Early events. There were 17 patient deaths (7.3%) in the hospital or within 30 days of surgery. Data on these perioperative deaths are summarized in Table II . All but one of the deaths occurred after bilateral renal artery reconstruction or unilateral reconstruction combined with simultaneous aortic repair. Perioperative mortality demonstrated significant and independent associations with advanced patient age (P = .001; hazard ratio, 1.1; 95% CI [1.1, 1.2]) and preoperative congestive heart failure (P = .04; hazard ratio, 2.9, 95% CI [1.1, 8.6]).
Perioperative morbidity contributing to perioperative death or prolonged hospitalization occurred in 70 patients (30%). These events included myocardial infarction (14 patients), cerebrovascular accident (7 patients), and significant arrhythmia (20 patients). In addition, 17 patients required more than 5 days of mechanical ventilatory support, and 20 patients were treated for pneumonia. Twenty-one patients demonstrated an increase in SCr, which resolved spontaneously in 17 instances and required permanent dialysis in four instances. Among the four patients in whom dialysis was initiated within 1 month of surgery, mean preoperative SCr and EGFR values were 3.8 mg/dL and 17.1 mL/min · m 2 , respectively.
A total of 580 intraoperative and postoperative renal duplex sonography scanning examinations were performed on follow-up. Overall, intraoperative revision of major B-scan defects were required in 12% of repairs. Each of 185 patients had at least one postrepair study, for a total of 276 renal artery reconstructions.
Late events. Follow-up data (mean, 38.3 months; range, 0.3-146.6 months) were available for 99% of surgical survivors. During follow-up, there were 72 additional deaths among the atherosclerotic patients with ischemic nephropathy. Cardiovascular events accounted for most (41%) of these late deaths, including myocardial infarction (22%) and cerebral vascular accident (6%). Noncardiovascular causes, including malignancies, accounted for 15% of the deaths. End-stage renal disease contributed to 22% of late deaths. Cause of death was unknown in 21% of cases. Forty-one patients progressed to eventual dialysis dependence. Of these 41 patients, 24 (59%) died on follow-up. The median survival time for patients reaching dialysis dependence was 15.9 months. By product-limit estimates, the survival among this group was 20% at 5 years. In all, postoperative renal duplex sonography scanning demonstrated that five renal artery reconstructions developed recurrent stenosis (2%) on follow-up. Recurrent stenosis did JOURNAL OF VASCULAR SURGERY 476 Hansen et al September 2000 not occur in patients with worsened postoperative renal function. Specifically, no patient progressing to dialysis dependence had anatomic failure of renal artery repair (defined by means of renal duplex scanning). Table III summarizes the proportional hazard regression analysis for time to dialysis or death from all causes during follow-up. Significant and independent associations were observed for (1) preoperative renal function and diabetes mellitus and (2) postoperative renal function both unchanged and worsened in comparison with renal function improved after surgery. A significant interaction between preoperative EGFR and risk of death or dialysis was observed among patients with unchanged renal function when preoperative EGFR fell below 23 mL/min · m 2 (Fig 1) .
Blood pressure response
Blood pressure response was determined from blood pressure measurements and medication requirements at least 8 weeks after surgery, as previously described. 16 Of the 215 patients surviving surgical repair, 11% were considered cured, 76% were considered improved, and 13% were considered failed. Blood pressure response among patients with ischemic nephropathy was not associated with either mortality from all causes (Fig 2, A) or cardiovascular mortality (Fig 2, B) on follow-up.
Renal function response
Renal function response was determined from EGFR as estimated from SCr as measured at least 3 weeks after surgery. A significant change in renal function was defined as a change of 20% or more in EGFR or removal from dialysis dependence.
Of 215 surgical survivors, 58% had improved renal function, 35% were considered to have function that was unchanged, and 7% were considered to have function that was worsened after surgical repair. Twenty-seven patients (75%) who had been dialysisdependent before surgery were removed permanently from dialysis after surgery. All surgical survivors being considered, there was a significant difference between preoperative EGFR and postoperative EGFR (23 ± .7 mL/min · m 2 and 31.7 ± 1.1 mL/min · m 2 , respectively; P = .0001). Table IV summarizes the influence of site of disease and extent of surgical repair on recovery of renal function. Repair of both unilateral and bilateral renal artery disease was associated with a statistically significant increase in postoperative EGFR. However, bilateral renal artery repair was associated with a significantly greater mean incremental increase in EGFR in comparison with unilateral repair (11.0 ± 1.3 vs 6.9 ± 1.7 mL/min · m 2 ; P = .001). Bilateral repair of significant disease to two kidneys led to the greatest mean increase in EGFR. Among preoperative parameters, men (men, 54% improvement; women, 68% improvement; P = .037) and patients with diabetes (diabetics, 51% improvement; nondiabetics, 60% improvement; P = .032) demonstrated a decreased rate of improved renal function after surgical repair. Table V relates preoperative SCr and dialysis dependence to postoperative renal function. As the preoperative SCr increased or renal function progressed to dialysis dependence, a greater proportion of patients demonstrated a 20% or more increase in EGFR. In those patients with the most severely impaired preoperative renal function, 75% were removed from dialysis dependence. This association between increased preoperative SCr and improved postoperative EGFR was significant (P = .01).
In contrast to what was seen with hypertension response, there were strong and independent rela- Table III) . For time to dialysis, significant interactions between preoperative EGFR and both unchanged and worsened renal function were observed (Table VI) . The product-limit estimates of dialysis-free survival according to postoperative renal function response are depicted in Fig 3. 
DISCUSSION
In the absence of criteria that accurately predict recovery of renal function, do the results from operation described in this experience support surgical intervention for ischemic nephropathy? A 7.3% perioperative mortality was observed. On mean follow-up of 38 months, 72 additional patients (33%) died or progressed to dialysis dependence. Patients who experienced incremental improvement in early excretory renal function demonstrated improved dialysis-free survival during follow-up, but only when compared with patients with unchanged or worsened function after operation. In the absence of a randomly selected comparative group managed medically without operation, this essential question remains unanswered.
Unfortunately, few data are available regarding the mortality or dialysis risk associated with untreated atherosclerotic renal artery disease, with or without renal insufficiency. Conlon et al 17 reported on all-cause mortality among patients chosen for cardiac catheterization studied simultaneously with abdominal aortography. 18 In this group, 15% of 1235 patients demonstrated at least one renal artery with ≥ 50% diameter-reducing stenosis. Among patients with renovascular disease, the 4-year estimated survival was 65%-significantly decreased in comparison with that for age-and sex-matched controls without renal artery stenosis. As determined by means of multivariate analysis, significant and independent predictors of mortality included the presence of renal artery disease, an elevated SCr level, and decreased left ventricular performance. Given these independent relationships among anatomic renal artery disease, elevated SCr level, and follow-up mortality, the poor survival observed in our patients unimproved after surgical treatment may approximate the expected mortality of patients with ischemic nephropathy managed medically without intervention. This notion is supported by Baboolac et al, 19 who reported on the mortality and dialysis risk of patients with renal artery disease managed without intervention. Over an 8-year period, these authors retrospectively identified 51 patients with angiographic evidence of bilateral renovascular disease (ie, ≥ 90% diameter-reducing renal artery stenosis, with at least 50% contralateral stenosis). Each of these patients had received medical treatment, but none had received renal artery intervention. By productlimit estimates, 40% of these patients died within 2 years of diagnosis and the progression to dialysis dependence was 35% at 5 years. All of these observations correlate closely with the estimates of death and dialysis dependence in our patients with unchanged renal function after surgery.
Surprisingly few reports on ischemic nephropathy relate function response after renal artery intervention to clinically relevant end-points-eventual dialysis dependence or death. Chaikof et al 20 Despite the absence of prospective data, clinical experience suggests that ischemic nephropathy can mediate a rapid decline in renal function. The rate of decline in function has been recently described for a patient subgroup characterized by a preoperative SCr level of at least 1.8 mg/dL with at least three measures of renal function before and after surgery. 16 Among patients with ischemic nephropathy proved by an immediate increase in renal function after surgery, the preoperative decline in EGFR exceeded 5% per week. Immediate improvement in renal function was also associated with a significant decrease in the rate of decline in postoperative EGFR. Conversely, patients with renal function unimproved after operation continued to decline in EGFR at a rate that was unchanged. These observations correlate with the relationship between renal function response and clinical outcome described in this report. Only patients with an incremental increase in EGFR after operation demonstrated improved dialysis-free survival on follow-up.
This relationship between early renal function response and dialysis-free survival has important implications. First, the method of intervention for ischemic nephropathy should be selected that provides maximal retrieval of renal function. This selection should consider the pattern of atherosclerotic disease typically found in this patient population. 2 In our experience, ostial atherosclerosis accounted for 97% of renal artery stenosis, 32% of renal artery disease was represented by complete occlusion, and 64% of patients had bilateral renal artery stenosis or occlusion. Second, clinical benefit after renal artery intervention probably applies only to those patients who demonstrate an incremental increase in excretory renal function. Consequently, the common practice of considering patients with unchanged renal function to be "preserved" or "stable" should be abandoned. Patients with unimproved renal function are not "preserved"; rather, they remain at high risk for both dialysis dependence and death. 11 Given the significant interaction between preoperative EGFR and death or eventual dialysis dependence for patients who are unchanged, this issue has greatest importance for patients with severe preoperative renal insufficiency (see Fig 1) .
The primary aim of this retrospective review was to examine the relationship between renal function response and dialysis-free survival. Although we believe that this analysis provides important information relative to the issue, bias inherent in our patient selection limits the general application of these observations. All consecutive patients with atherosclerotic renovascular disease and ischemic nephropathy were included for analysis. However, patients were selected for intervention on the basis of severe hypertension in combination with severe (≥ 80% diameterreducing stenosis or occlusion), surgically correctable renal artery lesions. Patients with mild hypertension and moderate renovascular disease in combination with renal insufficiency were excluded from surgical intervention. 2, 16 Moreover, patients with advanced renal insufficiency and dialysis-dependent ischemic nephropathy were most commonly chosen for intervention when the decline in renal function preceding surgery had been rapid and severe occlusive disease was present to the entire renal mass. 16, 21 The potential influence of this selection bias was most obvious among patients with severe preoperative renal insufficiency. Other authors have suggested that a marked elevation in SCr precludes meaningful recovery of renal function. 3, 5, 6 On the contrary, when surgical intervention was guided by the selection criteria described above rather than by the absolute value of preoperative SCr, increased SCr was associated with an increased probability of improved postoperative renal function (Table V) .
In addition to this selection bias, a few features of our surgical strategy deserve comment. The greatest incremental increase in EGFR occurred with simultaneous correction of all significant renovascular disease. As a result, complete renal revascularization was attempted at a single operation in every patient. 2 Our experience with renal artery occlusion has demonstrated potential recovery of renal function regardless of kidney size, angiographic evidence of collateralization, or reconstitution of the distal renal artery. 22 Consequently, each renal artery occlusion was explored in anticipation of repair. Nephrectomy was reserved for an unreconstructable renal artery to a kidney providing less than 10% to 20% of overall function by preoperative renography. Finally, a significant and independent relationship between failed surgical repair and eventual dialysis dependence has been demonstrated. 23 Renal artery repairs were examined with intraoperative duplex sonography September 2000 scanning to minimize these postoperative failures. 24 Major B-scan defects were revised before the completion of surgery, providing an estimated primary patency rate of 97% at 5 years. 23 The lack of association between hypertension response and estimated survival among patients with ischemic nephropathy deserves special comment. This observation does not agree with surgical results among patients with renovascular hypertension managed decades earlier. In this latter patient group, Dean et al 25 reported that beneficial blood pressure response (ie, cured or improved hypertension) was associated with a significant increase in estimated survival in comparison with a failed response. 25 There are several potential explanations of why our experience with ischemic nephropathy was different. First, the average length of follow-up for our patients with ischemic nephropathy was significantly shorter (3.3 years vs 17 years). Second, the average patient in this series was significantly older at the point of surgical intervention (66 years vs 50 years), and there was a significantly greater prevalence of extrarenal atherosclerosis (87% vs 40%). Finally, and probably most importantly, each patient in this review was selected on the basis of preoperative excretory renal insufficiency; in contrast, renal insufficiency was present in only 7% of patients previously reported. The strong independent effects of increased patient age and preoperative renal dysfunction may obscure any survival benefit conferred by a beneficial blood pressure response in the contemporary patient group with ischemic nephropathy.
In summary, surgical repair of renovascular disease can retrieve significant excretory renal function in selected patients with severe hypertension and ischemic nephropathy. Early renal function response appears to exert important effects on time to dialysis dependence and dialysis-free survival. Specifically, patients with improved renal function after surgery demonstrated freedom from dialysis dependence and improved dialysis-free survival that was significant and independent in comparison with patients whose renal function was unchanged or worsened. Most important, these results provide further support for a carefully controlled, prospective, randomized trial comparing operative renal artery repair, PTA, and medical management to confirm or refute the value of renal artery intervention in patients with ischemic nephropathy. September 2000 therapy, one group receiving the best medical therapy plus angioplasty and/or stenting, and a third group receiving the best medical therapy and surgery. If our interventional radiologists are able to dilate occluded renal arteries, we would anticipate accruing 210 patients over a 3-year period. If our radiologists are not able to dilate occluded renal arteries, we would need two more groups: one with patients with occluded renal arteries receiving the best medical therapy and another with patients with occluded renal arteries receiving the best medical therapy and surgery. In this case we would require 350 patients for the five groups accrued over 5 years.
Your second question regarded referral for treatment of patients with ischemic nephropathy. During your question you correctly noted that this is a sobering disease. I think that it is very important to recognize that atherosclerotic renal artery stenosis carries a poor prognosis, regardless of therapy.
The patients we operated on for ischemic nephropathy are highly selected. They are all extremely hypertensive. They all have increased serum creatinines. Two thirds of them have bilateral renal artery disease, and most of them were referred to us for ischemic nephropathy, not aneurysms or aortoiliac occlusive disease. Without a prospective randomized trial, we can only compare our patients with those described in other papers.
First I will talk about medical therapy. A recent study from Duke by Conlon looked at 1235 patients who were undergoing cardiac catheterization. While pulling out angiogram catheters, the authors did aortograms. Fifteen percent of the patients had renal artery disease, which they treated with medical therapy alone. They then prospectively followed those patients over 4 years and found that their survival was 67%, significantly worse than patients without renal artery disease. By multivariate analysis, renal artery disease and elevated creatinine were both associated with death.
We were able to remove 75% of the dialysis-dependent patients from dialysis after surgery. Patients with ischemic nephropathy who require dialysis have a dismal prognosis. When Mailloux looked at a series of patients beginning dialysis and stratified them based on cause of renal failure, the patients who had ischemic nephropathy did the worst. Their 5-year survival was 12%. We surmise that our subgroup of patients, who were dialysis dependent, had an extremely poor prognosis without an operation. Because we were able to remove three quarters of those patients from dialysis dependence, we feel that surgery was of great benefit to these patients.
Next, I will mention angioplasty and stenting. Two of the vascular fellows preceding me at Wake Forest, Dr Tim Oskin and Dr James Wong, reviewed the world literature from 1991 to 1999, looking specifically for patients who had stenting done for ostial stenosis. They found 350 patients in whom they could quantify the postprocedure renal function response. They found that only 15% of patients had an improved renal function response compared with 60% of the patients in our group. Again, we feel that we offer more of a benefit to patients with surgery than, as best as we can tell, patients get from renal artery stenting.
The 7% mortality associated with operation for ischemic nephropathy is important to note when considering treatment options for this patient population. But, because we feel that can help a large majority of these patients with surgery, we do not plan to change our referral pattern.
Your last question was in regard to intraoperative renal ischemia time. During this study we did not look at renal ischemia time, but we have examined it in a previous study. We looked at approximately 150 patients and found no relationship between intraoperative renal ischemia time and renal function response and long-term outcome.
Dr Jacob Robison (Mount Pleasant, SC). Your group has previously indicated that not only is the absolute value of the creatinine important, but maybe the time course of the deterioration may also be important. I wonder if you could tell us how that factored into your analysis.
Secondly, this seems like it would be ideally suited to decision analysis as a tool to determine quality-adjusted life years and see whether such effort is really worth it in the long run. I wonder if you might comment.
Thank you very much. Dr Cherr. As part of the selection process for surgery, we consider the rate of decline of renal function. Specifically, we feel that patients with a rapidly rising serum creatinine have a better chance of deriving benefit from surgery. We do not usually offer renal artery surgery to patients with an elevated creatinine that is stable or has been rising slowly.
Quality-adjusted life years are important concepts to consider in this patient population.
